Le Journal des Biotechs
by BOURSORAMA
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇫🇷FR · Investing#7810K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
5K to 15K🎙 ~2x weekly·155 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
10K to 30K🇫🇷100% - Active Followers
Loyal subscribers who consistently listen
3K to 9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHost
Recent guests
Recent episodes
Le Journal des biotechs : Pascal Prigent, directeur général de Genfit
Jul 15, 2026
22m 39s
Le Journal des biotechs: Alessandro Riva (Transgene), Jamila El Bougrini (Invest Securities)
Jul 8, 2026
45m 39s
Le Journal des biotechs : Fred Chereau (Sensorion), Frédéric Gomez (Pharmium Securities)
Jun 12, 2026
38m 13s
Le Journal des biotechs : Hervé Affagard (Maat Pharma), Didier Laurens (Advicenne)
May 28, 2026
30m 25s
Le journal des biotechs : Laurent Levy (Nanobiotix), Jamila El Bougrini (Invest Securities)
Apr 9, 2026
33m 41s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/15/26 | biotechhealthcare+3 | Pascal Prigent | IQIRVONASHnext+2 | — | GenfitPascal Prigent+5 | — | 22m 39s | ||
| 7/8/26 | biotechinvesting+3 | Jamila El BougriniAlessandro Riva | Invest SecuritiesTransgene+3 | — | biotechinvesting+3 | — | 45m 39s | ||
| 6/12/26 | biotechnologyinvestment+3 | Frédéric GomezFred Chereau | Pharmium SecuritiesSensorion+3 | — | biotechinvestment risk+3 | — | 38m 13s | ||
| 5/28/26 | biotechinvestment+3 | Hervé AffagardDidier Laurens | MaaT013MaaT Pharma+4 | — | biotechMaaT Pharma+3 | — | 30m 25s | ||
| 4/9/26 | biotech acquisitionsclinical advancements+3 | Laurent LevyJamila El Bougrini | ValnevaDBV Technologies+3 | — | biotechacquisitions+7 | — | 33m 41s | ||
| 3/18/26 | biotechnologyinterview+3 | Karine LignelJan Hoflack | Oncodesign Precision MedicineMichael J. Fox Foundation+1 | — | biotechOncodesign+5 | — | 15m 42s | ||
| 3/4/26 | biotechChina+3 | Cédric MoreauFrédéric Gomez | SofinnovaPharmium Securities+2 | — | biotechChina+5 | — | 36m 26s | ||
| 2/20/26 | biotech ecosystemhealthcare investment+3 | Mathieu CharvériatThierry Laugel | Kurma PartnersTHX Pharma+1 | — | biotechinvestment+6 | — | 33m 57s | ||
| 2/5/26 | biotech analysisinvestment opportunities+3 | Jamila El Bougrini | MedincellAbivax+2 | — | biotechinvestment+5 | — | 1h 28m 47s | ||
| 1/26/26 | biotechnologyinvestment+3 | Hervé Affagard | MaaT PharmaAudion | — | MaaT013MaaT033+3 | — | 17m 24s | ||
| 12/15/25 | biotechnologyclinical trials+4 | André Choulika | éti‑celIL‑2+3 | — | Cellectiséti-cel+5 | — | 17m 55s |
Showing 11 of 11
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Le Journal des Biotechs
Peaked at #78 in France, currently #78 in France.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| France | — | #78 | #78 | — |
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.